Unknown

Dataset Information

0

Activity of Sanguinarine against Candida albicans Biofilms.

ABSTRACT: Candida albicans biofilms show resistance to many clinical antifungal agents and play a considerable contributing role in the process of C. albicans infections. New antifungal agents against C. albicans biofilms are sorely needed. The aim of this study was to evaluate sanguinarine (SAN) for its activity against Candida albicans biofilms and explore the underlying mechanism. The MIC50 of SAN was 3.2 ?g/ml, while ?0.8 ?g/ml of SAN could suppress C. albicans biofilms. Further study revealed that ?0.8 ?g/ml of SAN could decrease cellular surface hydrophobicity (CSH) and inhibited hypha formation. Real-time reverse transcription-PCR (RT-PCR) results indicated that the exposure of C. albicans to SAN suppressed the expression of some adhesion- and hypha-specific/essential genes related to the cyclic AMP (cAMP) pathway, including ALS3, HWP1, ECE1, HGC1, and CYR1 Consistently, the endogenous cAMP level of C. albicans was downregulated after SAN treatment, and the addition of cAMP rescued the SAN-induced filamentation defect. In addition, SAN showed relatively low toxicity to human umbilical vein endothelial cells, the 50% inhibitory concentration (IC50) being 7.8 ?g/ml. Collectively, the results show that SAN exhibits strong activity against C. albicans biofilms, and the activity was associated with its inhibitory effect on adhesion and hypha formation due to cAMP pathway suppression.

SUBMITTER: Zhong H 

PROVIDER: S-EPMC5404597 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Activity of Sanguinarine against Candida albicans Biofilms.

Zhong Hua H   Hu Dan-Dan DD   Hu Gan-Hai GH   Su Juan J   Bi Shuang S   Zhang Zhuo-Er ZE   Wang Zheng Z   Zhang Ri-Li RL   Xu Zheng Z   Jiang Yuan-Ying YY   Wang Yan Y  

Antimicrobial agents and chemotherapy 20170424 5

<i>Candida albicans</i> biofilms show resistance to many clinical antifungal agents and play a considerable contributing role in the process of <i>C. albicans</i> infections. New antifungal agents against <i>C. albicans</i> biofilms are sorely needed. The aim of this study was to evaluate sanguinarine (SAN) for its activity against <i>Candida albicans</i> biofilms and explore the underlying mechanism. The MIC<sub>50</sub> of SAN was 3.2 μg/ml, while ≥0.8 μg/ml of SAN could suppress <i>C. albican  ...[more]

Similar Datasets

Unknown The Structure-Activity Relationship of Pterostilbene Against Candida albicans Biofilms.
| S-EPMC6155180 | biostudies-literature
Unknown Effect of tetrandrine against Candida albicans biofilms.
| S-EPMC3832530 | biostudies-literature
Unknown In vitro evaluation of antifungal activity of monolaurin against Candida albicans biofilms.
| S-EPMC4924139 | biostudies-literature
Unknown Artemisinins, new miconazole potentiators resulting in increased activity against Candida albicans biofilms.
| S-EPMC4291436 | biostudies-literature
Unknown In Vitro and In Vivo Antifungal Activity of Lichochalcone-A against Candida albicans Biofilms.
| S-EPMC4902220 | biostudies-literature
Unknown Activity of antimicrobial peptide mimetics in the oral cavity: I. Activity against biofilms of Candida albicans.
| S-EPMC2992321 | biostudies-literature
Unknown Nylon-3 polymers active against drug-resistant Candida albicans biofilms.
| S-EPMC4682891 | biostudies-literature
Unknown Garcinia xanthochymus Benzophenones Promote Hyphal Apoptosis and Potentiate Activity of Fluconazole against Candida albicans Biofilms.
| S-EPMC4576022 | biostudies-literature
Unknown CD101, a Novel Echinocandin, Possesses Potent Antibiofilm Activity against Early and Mature Candida albicans Biofilms.
| S-EPMC5786756 | biostudies-literature
Unknown Plasticity of Candida albicans Biofilms.
| S-EPMC4981664 | biostudies-other